Neuronoff Inc., a Cleveland startup developing minimally invasive neuromodulation systems, has been awarded or recommended ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

Storm started suffering seizures when he was 12 weeks old, and now he has to take 31 pills a day to manage his life-threatening condition.

In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

Movement is a complex process governed by a network of neuronal circuits spread across multiple regions of the nervous system ...

The University of California, Davis (UC Davis) veterinary hospital recently announced the establishment of a Neurosurgery ...

Scholar Rock (SRRK), a late-stage biopharmaceutical company developing innovative treatments for spinal muscular atrophy, ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...